Ethics & Informed Consent: Retrospective Case-Control Study (New Zealand)

1. Ethical Principles & Legislative Framework

In research involving human participants, securing ethical clearance is a critical first step. For a Retrospective Case-Control Study being conducted in New Zealand, study designs must align with the primary regulatory legislation: National Ethical Standards for Health and Disability Research. This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.

Administrative review and formal approval are managed by a local or regional Health and Disability Ethics Committee (HDEC). Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.

2. Study Design Elements & Reporting Integrity

For a Retrospective Case-Control Study, the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.

Study Classification: Minimal Risk (Exempt or Expedited)

Case-control studies rely on historical data extraction. When active consent is unfeasible, a waiver can be requested by proving secure de-identification and minimal participant risk.

To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: STROBE guidelines.

3. Informed Consent & Information Sheet Guidelines

A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:

• Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
• Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
• Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under Privacy Act 2020 & Health Information Privacy Code.
• Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
• Ethics Board Contact Information: Provide the contact details of the reviewing Health and Disability Ethics Committee (HDEC) so participants can reach out if they have questions or concerns.

Research Ethics, Clinical Trials & Institutional Governance

The data capture guidelines match the Declaration of Helsinki ethical principles to protect individual identifiers from disclosure. The protocol must outline safe pathways, particularly if any minor deception in psychological research is used in questionnaires. The consenting procedure must follow the ethical principles of informed consent, ensuring participants can opt out anytime. While observational work rarely requires a clinical trial registration, a signed clinical trial agreement contract is required for health networks. Submitting a verified data sharing agreement is necessary to secure final research ethics approval from the Health and Disability Ethics Committee (HDEC). In accordance with New Zealand participant safety rules, investigators must complete certified human protection modules before recruitment begins.

4. Regulatory Checklist Table

To streamline your ethical review submission, use the structured alignment checklist below:

6. Frequently Asked Questions